Carasent ASA completes the acquisition of Medrave Software AB and increases the
share capital by issuing consideration shares.
Reference is made to the stock exchange announcement on 15 December 2021 by
Carasent ASA ("Carasent" or the "Company") regarding the Company's acquisition
of Medrave Software AB, including its fully-owned Norwegian subsidiary Medrave
Software AS (together "Medrave").
The signed acquisition was subject to customary closing conditions with expected
closing during January 2022. As of today, the closing conditions have been met
and the purchase price of SEK 134 million has been settled.
The share capital increase pertaining to the SEK 23.75 million reinvestment by
key employees (the "Reinvestment") was resolved by the Board of Directors of the
Company (the "Board") on 11 January 2022 pursuant to an authorization granted by
the Company's general meeting held 27 October, 2021 (the "Authorization").
The share capital will be increased by NOK 835,684.81, divided into 627,391
shares, each with nominal value of NOK 1.332. Following registration of the
share capital increase pertaining to the Reinvestment, the Company will have a
share capital of NOK 105,554,537.14, divided into 79,245,148 shares, each with
nominal value of NOK 1.332.
About the companies
Carasent ASA was founded in 1997. In May 2018 the Swedish company Evimeria EMR
AB, a company providing cloud-based medical record services to the health care
industry, was acquired. In December 2020 Carasent ASA acquired the Norwegian
company Avans Soma AS, a developer of leading medical record systems and IT
solutions in the Norwegian health care market. Metodika AB, provider of Metodika
EPM, a highly competitive all in one solution for medium sized private clinics
and hospitals in Europe, was acquired in May 2021. Carasent's strategy is to
develop and expand digitalization that helps customers in providing efficient
and qualitative health care services in the Scandinavian market.
Medrave Software AB:
Medrave is a market leader in Scandinavia within quality improvement software
for healthcare practices within primary care and secondary outpatient care.
Their quality improvement solution automatically collects and sorts data,
analyze and visualize, tracks and benchmarks KPIs, and provides automatic
reporting to healthcare professionals. It was established by Per Stenström and
Svein Gjelstad in 2007. The company is situated in Stockholm with a satellite
office in Norway (Tønsberg) and has 16 employees.
For further information, please contact:
Dennis Höjer, CEO Carasent ASA Phone: +46 733 28 49 22
Svein Martin Bjørnstad, CFO Carasent ASA Phone: +47 979 69 493
Johan Lindqvist, Chairman Carasent ASA Phone: +46 733 550935